WHO monographs on selected medicinal plants - travolekar.ru
WHO monographs on selected medicinal plants - travolekar.ru
WHO monographs on selected medicinal plants - travolekar.ru
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<str<strong>on</strong>g>WHO</str<strong>on</strong>g> <str<strong>on</strong>g>m<strong>on</strong>ographs</str<strong>on</strong>g> <strong>on</strong> <strong>selected</strong> <strong>medicinal</strong> <strong>plants</strong><br />
Major chemical c<strong>on</strong>stituents<br />
The major chemical c<strong>on</strong>stituents of the oil are triacyl glycerols c<strong>on</strong>taining<br />
an unsaturated and hydroxylated C 18<br />
fatty acid: (R)-(+)-12-hydroxy-Zoctadec-9-enoic<br />
acid, also known as ricinoleic acid (85–92%) (1, 17). It<br />
should be noted that ricinoleic acid occurs primarily as its precursor triglyceride,<br />
ricinolein (70–77% of the oil) (20). Other fatty acids found are:<br />
palmitic (2% maximum), stearic (2.5% maximum), oleic and isomers<br />
(2.5–6.0%), linoleic (2.5–7.0%), linolenic (2.5% maximum), eicosenoic<br />
(1.0% maximum), other acids (1.0% maximum) (1). The st<strong>ru</strong>cture of ricinoleic<br />
acid is presented below.<br />
Ricinoleic acid<br />
H 3 C<br />
H<br />
OH<br />
CO 2 H<br />
Medicinal uses<br />
Uses supported by clinical data<br />
N<strong>on</strong>e.<br />
Uses described in pharmacopoeias and well established documents<br />
Short-term treatment (3–5 days) for acute c<strong>on</strong>stipati<strong>on</strong> when other dietary<br />
methods or bulk-forming laxatives have not provided adequate relief.<br />
As a cathartic for use in bowel evacuati<strong>on</strong> prior to surgery (21). Used<br />
externally for topical dermatoses and dermatitis (5, 6).<br />
Uses described in traditi<strong>on</strong>al medicine<br />
Used as an emmenagogue, to induce labour, for the treatment of burns,<br />
br<strong>on</strong>chitis, diarrhoea, itching, earache, haemorrhoids, pneum<strong>on</strong>ia, rheumatism<br />
and sprains (6, 22, 23).<br />
Pharmacology<br />
Experimental pharmacology<br />
Anti-inflammatory activity<br />
Pharmacological studies suggest that ricinoleic acid has a similar activity to<br />
that of capsaicin, and further suggest a potential interacti<strong>on</strong> of ricinoleic<br />
acid with sensory neuropeptide-mediated neurogenic inflammati<strong>on</strong> (24).<br />
The pro-inflammatory and anti-inflammatory effects of ricinoleic acid<br />
were assessed in an experimental model of blepharitis induced by intradermal<br />
injecti<strong>on</strong> of carrageenan in guinea-pig eyelids. Topical treatment<br />
with ricinoleic acid (10–100.0 mg/guinea-pig) or capsaicin (1–10 mg/guinea-pig)<br />
caused eyelid reddening and oedema. At lower doses both d<strong>ru</strong>gs<br />
274